IL-12 deficiency transiently improves viral clearance during the late phase of respiratory tract infection with influenza A virus in mice

Antiviral Research

Volumn 70, Issue 2, 2006, Pages 75-84

  van der Sluijs, Koenraad F ^a   van Elden, Leontine J R ^b   Xiao, Yanling ^c   Arens, Ramon ^c   Nijhuis, Monique ^b   Schuurman, Rob ^b   Florquin, Sandrine ^a   Jansen, Henk M ^a   Lutter, René ^a   van der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Influenza; Innate response; Interleukin 12; Pneumonia

Indexed keywords

CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; PROTEIN P35;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CLEARANCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; EXPERIMENTAL INFECTION; IMMUNE RESPONSE; INFLUENZA VIRUS A; KNOCKOUT GENE; KNOCKOUT MOUSE; LUNG; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN FUNCTION; RESPIRATORY TRACT INFECTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TISSUE LEVEL; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS LOAD; WILD TYPE;

ANIMALS; BRONCHOALVEOLAR LAVAGE; FLOW CYTOMETRY; IMMUNOGLOBULINS; INFLUENZA A VIRUS; INTERLEUKIN-12; LUNG; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; RESPIRATORY TRACT INFECTIONS; T-LYMPHOCYTES; VIRAL LOAD;

ANIMALIA; INFLUENZA A VIRUS; INFLUENZAVIRUS A;

EID: 33646053838     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.01.007     Document Type: Article

References (44)

1. Biron C.A. Initial and innate responses to viral infections-pattern setting in immunity or disease. Curr. Opin. Microbiol. 2 (1999) 374-381
2. Braciale T.J., Morrison L.A., Sweetser M.T., Sambrook J., Gething M.J., and Braciale V.L. Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes. Immunol. Rev. 98 (1987) 95-114
3. Brydon E.W., Smith H., and Sweet C. Influenza A virus-induced apoptosis in bronchiolar epithelial (NCI-H292) cells limits pro-inflammatory cytokine release. J Gen. Virol. 84 (2003) 2389-2400
4. D'Andrea A., Rengaraju M., Valiante N.M., Chehimi J., Kubin M., Aste M., Chan S.H., Kobayashi M., Young D., and Nickbarg E. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176 (1992) 1387-1398
5. Doherty P.C., Topham D.J., Tripp R.A., Cardin R.D., Brooks J.W., and Stevenson P.G. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159 (1997) 105-117
6. Grohmann U., Belladonna M.L., Vacca C., Bianchi R., Fallarino F., Orabona C., Fioretti M.C., and Puccetti P. Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma. J. Immunol. 167 (2001) 221-227
7. Gubler U., Chua A.O., Schoenhaut D.S., Dwyer C.M., McComas W., Motyka R., Nabavi N., Wolitzky A.G., Quinn P.M., Familletti P.C., and Gately M.K. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88 (1991) 4143-4147
8. Ha S.J., Lee S.B., Kim C.M., Shin H.S., and Sung Y.C. Rapid recruitment of macrophages in interleukin-12-mediated tumour regression. Immunology 95 (1998) 156-163
9. Ha S.J., Lee C.H., Lee S.B., Kim C.M., Jang K.L., Shin H.S., and Sung Y.C. A novel function of IL-12p40 as a chemotactic molecule for macrophages. J. Immunol. 163 (1999) 2902-2908
10. Ha S., Kim D.J., Baek K.H., Yun Y.D., and Sung Y.C. IL-23 induces stronger sustained CTL and Th1 immune responses than IL-12 in hepatitis C virus envelope protein 2 DNA immunization. J. Immunol. 172 (2004) 525-532
11. Hamilton-Easton A., and Eichelberger M. Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice. J. Virol. 69 (1995) 6359-6366
12. Heinzel F.P., Hujer A.M., Ahmed F.N., and Rerko R.M. In vivo production and function of IL-12 p40 homodimers. J. Immunol. 158 (1997) 4381-4388
13. Julkunen I., Sareneva T., Pirhonen J., Ronni T., Melen K., and Matikainen S. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev. 12 (2001) 171-180
14. Katze M.G., He Y., and Gale Jr. M. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2 (2002) 675-687
15. Kawakami K., Tohyama M., Xie Q., and Saito A. IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin. Exp. Immunol. 104 (1996) 208-214
16. Kopf M., Brombacher F., and Bachmann M.F. Role of IgM antibodies versus B cells in influenza virus-specific immunity. Eur. J. Immunol. 32 (2002) 2229-2236
17. Kostense S., Sun W.H., Cottey R., Taylor S.F., Harmeling S., Zander D., Small Jr. P.A., and Bender B.S. Interleukin 12 administration enhances Th1 activity but delays recovery from influenza A virus infection in mice. Antiviral Res. 38 (1998) 117-130
18. Kurokawa M., Tsurita M., Brown J., Fukuda Y., and Shiraki K. Effect of interleukin-12 level augmented by Kakkon-to, a herbal medicine, on the early stage of influenza infection in mice. Antiviral Res. 56 (2002) 183-188
19. Lankford C.S., and Frucht D.M. A unique role for IL-23 in promoting cellular immunity. J. Leukoc. Biol. 73 (2003) 49-56
20. Lauw F.N., Dekkers P.E., te Velde A.A., Speelman P., Levi M., Kurimoto M., Hack C.E., van Deventer S.J., and van der Poll T. Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees. J. Infect. Dis. 179 (1999) 646-652
21. Lauw F.N., Branger J., Florquin S., Speelman P., van Deventer S.J., Akira S., and van der Poll T. IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. J. Immunol. 168 (2002) 372-379
22. Ling P., Gately M.K., Gubler U., Stern A.S., Lin P., Hollfelder K., Su C., Pan Y.C., and Hakimi J. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 154 (1995) 116-127
23. Liu Z., Geboes K., Heremans H., Overbergh L., Mathieu C., Rutgeerts P., and Ceuppens J.L. Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis. Eur. J. Immunol. 31 (2001) 1550-1560
24. Monteiro J.M., Harvey C., and Trinchieri G. Role of interleukin-12 in primary influenza virus infection. J. Virol. 72 (1998) 4825-4831
25. Murphy B.R., and Webster R.G. Orthomyxoviruses. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fields Virology. 3rd ed. (1996), Lippincott-Raven publishers, Philadelphia 1407
26. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., Zonin F., Vaisberg E., Churakova T., Liu M., Gorman D., Wagner J., Zurawski S., Liu Y., Abrams J.S., Moore K.W., Rennick D., de Waal-Malefyt R., Hannum C., Bazan J.F., and Kastelein R.A. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13 (2000) 715-725
27. Palmer E.M., Farrokh-Siar L., Maguire van Seventer J., and van Seventer G.A. IL-12 decreases activation-induced cell death in human naive Th cells costimulated by intercellular adhesion molecule-1. I. IL-12 alters caspase processing and inhibits enzyme function. J. Immunol. 167 (2001) 749-758
28. Papp Z., Middleton D.M., Rontved C.M., Foldvari M., Gordon J.R., and Baca-Estrada M.E. Transtracheal administration of interleukin-12 induces neutrophil responses in the murine lung. J. Interferon Cytokine Res. 20 (2000) 191-195
29. Pearlman E., Lass J.H., Bardenstein D.S., Diaconu E., Hazlett Jr. F.E., Albright J., Higgins A.W., and Kazura J.W. IL-12 exacerbates helminth-mediated corneal pathology by augmenting inflammatory cell recruitment and chemokine expression. J. Immunol. 158 (1997) 827-833
30. Pirhonen J., Matikainen S., and Julkunen I. Regulation of virus-induced IL-12 and IL-23 expression in human macrophages. J. Immunol. 169 (2002) 5673-5678
31. Pirtskhalaishvili G., Shurin G.V., Esche C., Cai Q., Salup R.R., Bykovskaia S.N., Lotze M.T., and Shurin M.R. Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins. Br. J. Cancer 83 (2000) 506-513
32. Reed L.J., and Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27 (1938) s493-s497
33. Renegar K.B., Small Jr. P.A., Boykins L.G., and Wright P.F. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J. Immunol. 173 (2004) 1978-1986
34. Romani L., Puccetti P., and Bistoni F. Interleukin-12 in infectious diseases. Clin. Microbiol. Rev. 10 (1997) 611-636
35. Russell T.D., Yan Q., Fan G., Khalifah A.P., Bishop D.K., Brody S.L., and Walter M.J. IL-12 p40 homodimer-dependent macrophage chemotaxis and respiratory viral inflammation are mediated through IL-12 receptor beta1. J. Immunol. 171 (2003) 6866-6874
36. Sareneva T., Matikainen S., Kurimoto M., and Julkunen I. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. J. Immunol. 160 (1998) 6032-6038
37. Treanor J.J. Orthomyxoviridae: influenza virus. In: Mandell G.L., Douglas D.R., Bennett E., and Dolin R. (Eds). Principles and Practice of Infectious Diseases. 5th ed. (2000), Churchill Livingston, New York 1834-1835
38. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3 (2003) 133-146
39. Tsurita M., Kurokawa M., Imakita M., Fukuda Y., Watanabe Y., and Shiraki K. Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection. J. Pharmacol. Exp. Ther. 298 (2001) 362-368
40. van Elden L.J.R., Nijhuis M., Schipper P., Schuurman R., and van Loon A.M. Simultaneous detection of influenza virus A and B using real-time quantitative PCR. J. Clin. Microbiol. 39 (2001) 196-200
41. van der Sluijs K.F., van Elden L., Nijhuis M., Schuurman R., Florquin S., Jansen H.M., Lutter R., and van der Poll T. Toll-like receptor 4 is not involved in host defense against respiratory tract infection with Sendai virus. Immunol. Lett. 89 (2003) 201-206
42. van der Sluijs K.F., van Elden L.J.R., Arens R., Nijhuis M., Schuurman R., Kwakkel G.J., Florquin S., Akira S., Jansen H.M., Lutter R., and van der Poll T. Enhanced viral clearance in IL-18 deficient mice after pulmonary infection with influenza A virus. Immunology 114 (2005) 112-120
43. Wark P.A., Johnston S.L., Bucchieri F., Powell R., Puddicombe S., Laza-Stanca V., Holgate S.T., and Davies D.E. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J. Exp. Med. 201 (2005) 937-947
44. Xiao Y., Hendriks J., Langerak P., Jacobs H., and Borst J. CD27 is acquired by primed B cells at the centroblast stage and promotes germinal center formation. J. Immunol. 172 (2004) 7432-7441